510(k) Report

510(k) · Cleared

Cleared

Low Dose CT Lung Cancer Screening Option

K180901510(k) TraditionalCleared May 16, 201840-day reviewClass II21 CFR 892.1750

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Hitachi Healthcare Americas · JAK System, X-Ray, Tomography, Computed

Cleared on May 16, 2018 as substantially equivalent to K153444 (Philips Medical Systems (Cleveland), Inc., 2016) after a 40-day review. Its family tree reaches back 6 generations to 1993.

Decided
May 16, 2018
Review
40 days
Class
Class II
Product code
JAK
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K930090 (1993). 11 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 6 generations backK930090 HelicatElscint, Inc. · 1993
  2. 5 generations backK961464 Select/SPElscint, Inc. · 1996 · Recalled
  3. 4 generations backK982060 Volumax CT Imaging SystemElscint, Inc. · 1998
  4. 3 generations backK012009 MX8000 Idt CT SystemMarconi Medical Systems, Inc. · 2001 · Recalled
  5. 2 generations backK033326 Philips Plus Computed Tomography SystemPhilips Medical Systems, Inc. · 2003 · Recalled
  6. 1 generation backK153444 Philips Multislice CT System with Low Dose CT Lung CancerPhilips Medical Systems (Cleveland), Inc. · 2016
  7. This deviceK180901 Low Dose CT Lung Cancer Screening OptionHitachi Healthcare Americas · 2018
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K930090HelicatElscint, Inc.1993—
−5K961464Select/SPElscint, Inc.19963
−4K982060Volumax CT Imaging SystemElscint, Inc.1998—
−3K012009MX8000 Idt CT SystemMarconi Medical Systems, Inc.200161
−2K033326Philips Plus Computed Tomography SystemPhilips Medical Systems, Inc.2003131
−1K153444Philips Multislice CT System with Low Dose CT Lung CancerPhilips Medical Systems (Cleveland), Inc.2016—
0 (this device)K180901Low Dose CT Lung Cancer Screening OptionHitachi Healthcare Americas2018—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199420
199510
199710
200110
FIG. 1 — Lineage of K180901, 1993–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JAK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JAK device

  1. #1 K230223 iCAC Devicescore 23.5 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K153444Philips Multislice CT System with Low Dose CT Lung Cancer
Summary page 4
…Radiology Predicate Device Name(s) Trade/Proprietary Name: Philips Multislice CT System with Low Dose CT Lung Cancer Screening K153444 (Philips Brillance CT 64-channel) Regulation Number: 21 CFR 892.1750 Regulation Name: Computed tomography x-ray s…
Philips Medical Systems (Cleveland), Inc.2016—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 25 years and passes through 5 companies; a new generation was cleared every 3.0 years on median.
  • 4 of the 11 ancestors have a recall of any class.

How does its category compare?

All JAK devices

JAK System, X-Ray, Tomography, Computed: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · JAK

27in 2025

2007: 142008: 262009: 152010: 72011: 162012: 282013: 172014: 302015: 302016: 252017: 292018: 242019: 282020: 302021: 202022: 302023: 272024: 262025: 272026 (partial year): 21
2007high 30 (2014) · low 7 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JAK

141in 2025

2007: 27 days median2008: 42 days median2009: 31 days median2010: 92 days median2011: 155 days median2012: 121 days median2013: 132 days median2014: 200 days median2015: 140 days median2016: 129 days median2017: 96 days median2018: 114 days median2019: 94 days median2020: 112 days median2021: 145 days median2022: 131 days median2023: 139 days median2024: 141 days median2025: 141 days median2026 (partial year): 167 days median
2007high 200 (2014) · low 27 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JAK

17in 2025

2007: 112008: 162009: 292010: 512011: 342012: 232013: 112014: 102015: 282016: 442017: 332018: 102019: 52020: 82021: 152022: 92023: 92024: 202025: 172026 (partial year): 23
2007high 51 (2010) · low 5 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JAK

219in 2025

2007: 762008: 1202009: 1052010: 1192011: 2052012: 1922013: 4142014: 3082015: 4542016: 3652017: 3382018: 5432019: 2332020: 1772021: 2612022: 1992023: 3102024: 2122025: 219
2007high 543 (2018) · low 76 (2007)2025

MAUDE reports naming product code JAK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200714271176
2008264216120
2009153129105
201079251119
20111615534205
20122812123192
20131713211414
20143020010308
20153014028454
20162512944365
2017299633338
20182411410543
201928945233
2020301128177
20212014515261
2022301319199
2023271399310
20242614120212
20252714117219
20262116723—

What is it indicated for?

The Low Dose CT Lung Cancer Screening Option for the SCENARIA and SUPRIA CT systems is indicated for using low dose CT for lung cancer screening. The screening must be conducted with the established program criteria and protocols that have been approved and published by a governmental body, a professional medical society, and/or Hitachi. Some examples of published articles can be found at the American College of Radiology® (ACR) website: *…

Read the full statement (159 words)

The Low Dose CT Lung Cancer Screening Option for the SCENARIA and SUPRIA CT systems is indicated for using low dose CT for lung cancer screening. The screening must be conducted with the established program criteria and protocols that have been approved and published by a governmental body, a professional medical society, and/or Hitachi.

Some examples of published articles can be found at the American College of Radiology® (ACR) website:

* ACR-SCBT-MR-SPR Practice Parameter for the Performance of Thoracic Computed Tomography (CT) Res. 10 —2013

* ACR-STR Practice Parameter for the Performance and Reporting of Lung Cancer Screening Thoracic Computed Tomography (CT) Res. 4 — 2014

* Lung Cancer Screening Technical Specifications

* Lung Cancer Screening Resources

In addition, examples of published articles can be found at the American Association of Physicists Medicine (AAPM) website:

» Lung Cancer Screening CT Protocols Version 4.0, 02/23/16

* AAPM Report No. 96: The Measurement, Reporting, and Management of Radiation Dose in CT

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K180901: Low Dose CT Lung Cancer Screening Option.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K180901

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026